HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel neuroprotective effect of cisternal and intra-cerebral magnesium sulfate solution infusion on delayed cerebral death in rat hippocampal neurons after transient global ischemia.

Abstract
Several neuroprotective strategies such as barbiturate coma and hypothermic therapies have been promising in experimental studies but had limited efficacies in clinical trials. Magnesium ion has vasodilator and neuroprotective properties as a natural calcium blocker. The neuroprotective effects of cisternal and intra-cerebral infusion of magnesium sulfate (MgSO(4)) solution were evaluated against delayed neuronal death (DND) of CA1 hippocampal pyramidal neurons, and the involvement of changes in cerebral blood flow (CBF) and metabolism were investigated. Osmotic pumps with various MgSO(4) solutions were embedded in the Sprague Dawley rat backs on day 1 and either cisternal or intra-cerebral (left CA1) infusion started. Global ischemic insult for 10 min was induced on day 3, and the numbers of surviving neurons and dead neurons in the CA1 region were evaluated by hematoxylin-eosin and Fluoro-Jade B staining, respectively, on day 7. The regional CBF and glucose utilization rate (CMRglc) were determined by autoradiographic methods using [(14)C]iodoantipyrine and [(14)C]deoxyglucose, respectively, on day 5 after the start of either cisternal or intra-cerebral infusion. In the cisternal infusion experiment, 100 mmol/lMgSO(4) solution significantly increased the number of surviving neurons and decreased the number of dead neurons. In the intra-cerebral infusion experiment, 1 mmol/l MgSO(4) and 10 mmol/lMgSO(4) solution significantly increased the number of surviving neurons and decreased the number of dead neurons in the infusion side in dose-dependent manner. Neither regional CBF or CMRglc changed significantly in the CA1 of the hippocampus. Pretreatment with either cisternal or intra-cerebral infusion with MgSO(4) solution can provide neuroprotection against DND without changing the CBF and metabolism.
AuthorsKentaro Mori, Takuji Yamamoto, Yasuaki Nakao, Masahiro Miyazaki, Junko Iwata, Masaru Tamura, Toshihiko Shiroishi
JournalBrain research (Brain Res) Vol. 1480 Pg. 72-80 (Oct 22 2012) ISSN: 1872-6240 [Electronic] Netherlands
PMID22842083 (Publication Type: Journal Article)
CopyrightCopyright © 2012. Published by Elsevier B.V.
Chemical References
  • Neuroprotective Agents
  • Magnesium Sulfate
Topics
  • Animals
  • Brain Ischemia (drug therapy, physiopathology)
  • CA1 Region, Hippocampal (drug effects, physiopathology)
  • Cell Count
  • Cell Death (drug effects)
  • Magnesium Sulfate (administration & dosage, pharmacology, therapeutic use)
  • Neurons (drug effects)
  • Neuroprotective Agents (administration & dosage, pharmacology, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: